kabutan

K Pharma, Jan-Sep (Cumulative 3Q) Net Income Loss Widens, Jul-Sep Net Income Loss Widens

Wed Nov 12, 2025 4:00 pm JST Earnings

4896 K Pharma,Inc. 【J-GAAP】

Earnings Report

K Pharma,Inc. <4896> [TSE Growth] announced its financial results after the market closed on November 12th (16:00). The net loss (non-consolidated) for the cumulative third quarter of the fiscal year ending December 2025 (January to September) expanded to a loss of 681 million yen (compared to a loss of 624 million yen in the same period last year).

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the net loss for the October to December period (4Q) is expected to expand to a loss of 455 million yen (compared to a loss of 222 million yen in the same period last year).

In the most recent three-month period, from July to September (3Q), the net loss expanded to loss of 237 million yen (compared to a loss of 198 million yen in the same period last year).

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Sep, 2023 1,000 515 508 398 40.3 147.7 Nov 13, 2023 J-GAAP
Jan - Sep, 2024 0 -620 -619 -624 -53.8 ー Nov 14, 2024 J-GAAP
Jan - Sep, 2025 0 -668 -666 -681 -58.8 ー Nov 12, 2025 J-GAAP
YoY － -7.7% -7.6% -9.1% -9.2%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 0 -413 -414 -420 -36.2 0 Feb 13, 2025 J-GAAP
Jul - Dec, 2025 Guidance ー -686 -685 -692 -59.6 0 Aug 14, 2025 J-GAAP
YoY － -66.1% -65.5% -64.8% -64.7%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 1,000 366 344 260 25.4 0 Feb 14, 2024 J-GAAP
Dec, 2024 0 -836 -836 -846 -72.9 0 Feb 13, 2025 J-GAAP
Dec, 2025 Guidance ー -1,123 -1,122 -1,136 -97.9 0 Jul 14, 2025 J-GAAP
YoY － -34.3% -34.2% -34.3% -34.2%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2024 0 -197 -197 -198 -17.1 -Inf Nov 14, 2024 J-GAAP
Oct - Dec, 2024 0 -216 -217 -222 -19.1 -Inf Feb 13, 2025 J-GAAP
Jan - Mar, 2025 0 -198 -198 -199 -17.2 -Inf May 15, 2025 J-GAAP
Apr - Jun, 2025 0 -239 -239 -245 -21.2 -Inf Aug 14, 2025 J-GAAP
Jul - Sep, 2025 0 -231 -229 -237 -20.5 -Inf Nov 12, 2025 J-GAAP
YoY － -17.3% -16.2% -19.7% -19.8%

Related Articles